信息搜索
信息关键字：药
  
『查询2022年信息』  『查询2021年信息』  『查询2020年信息』  『查询2019年信息』  『查询2018年信息』  『查询2017年信息』  『查询2016年信息』
『查询2015年信息』  『查询2014年信息』  『查询2013年信息』  『查询2012年信息』  『查询2011年信息』  『查询2010年信息』  『查询2009年信息』

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]

·买爆了，创55周新高，重点扫货股曝光，北上资金重金出击！“神药”光环消失，中药龙头近腰斩，8亿资金出逃2023-1-15 13:28:09
·发力抗新冠新药苗药龙头出手！有望填补临床用药空白2023-1-14 11:16:56
·新冠抗病毒药究竟有何功效？针对哪类人群？这篇文章说清楚了2023-1-14 8:22:44
·业绩惨淡、高管频变，基石药业前舵手能助恒瑞医药扭转乾坤？2023-1-14 4:27:57
·德全药品盐酸奥普力农注射液获得国家药品监督管理局药品注册证书2023-1-14 3:49:56
·华仁药业2022年预计净利1.52亿-1.86亿同比增长17%-43%自产产品销量稳中有升2023-1-14 0:56:30
·毕得医药2022年度净利1.46亿同比增长49%订单增加、销量增长2023-1-14 0:31:01
·股票行情快报：仟源医药（300254）1月13日主力资金净买入7.54万元2023-1-13 23:52:46
·瑞银医药团队：2023年看好两大主题、五大子行业！2023-1-13 23:39:40
·股票行情快报：启迪药业（000590）1月13日主力资金净卖出1659.90万元2023-1-13 22:09:22
·国家医保局：持续挤压药品耗材虚高价格水分引导新冠治疗药合理形成价格2023-1-13 21:20:13
·国药现代2022年度净利6.27亿同比增长10.26%制剂产品带量采购范围不断扩大2023-1-13 20:20:47
·高管频换！江宁军履新，能否带“医茅”恒瑞医药走出周期漩涡？2023-1-13 19:36:44
·皓元医药：多名股东拟减持合计不超4.56%股份2023-1-13 18:51:54
·贵州百灵：与中国中医科学院中药研究所签订技术转让合同2023-1-13 18:46:08
·赛升药业：子公司赛而生物获得高新技术企业证书可享受相关税收优惠政策2023-1-13 15:41:07
·“神药”光环褪去股价几近腰斩以岭药业前路几何？2023-1-13 12:16:04
·以岭药业回应网民讣告提及连花清瘟！价格战开打？特斯拉之后，问界宣布大降价2023-1-13 12:11:33
·重磅！又一款进口新冠药今日上市销售！首发报价1500元/瓶2023-1-13 11:02:14
·老百姓大药房从接连违规到捐药背面：狂收购，毛利率困境难解2023-1-13 10:54:37

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]